| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |